Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sunobinop tosylate by Imbrium Therapeutics for Insomnia: Likelihood of Approval
Sunobinop tosylate is under clinical development by Imbrium Therapeutics and currently in Phase II for Insomnia. According to GlobalData, Phase...
Sunobinop tosylate by Imbrium Therapeutics for Alcohol Dependence: Likelihood of Approval
Sunobinop tosylate is under clinical development by Imbrium Therapeutics and currently in Phase II for Alcohol Dependence. According to GlobalData,...
Sunobinop tosylate by Imbrium Therapeutics for Overactive Bladder: Likelihood of Approval
Sunobinop tosylate is under clinical development by Imbrium Therapeutics and currently in Phase I for Overactive Bladder. According to GlobalData,...